Up-regulation of p21(WAF1/CIP1) in psoriasis and after the application of irritants and tape stripping

Abstract

p21(WAF1/CIP1) is a nucleoprotein that was initially characterized by its ability to be regulated transcriptionally by p53 and by its ability to mediate growth arrest by binding to cyclin-dependent kinases. Although p21(WAF1/CIP1) is thought to mediate the effects of p53 in causing growth arrest, p21(WAF1/CIP1) is also regulated in a p53-independent manner, e.g., during terminal differentiation of some cell lines. Growth factors including epidermal growth factor also induce p21(WAF1/CIP1) through p53-independent pathways. Because the epidermal growth factor signaling pathway is abnormal in psoriatic epidermis, we studied p21(WAF1/CIP1) expression, using in situ hybridization and immunohistochemistry, in psoriasis. Both p21(WAF1/CIP1) mRNA and protein were significantly elevated in untreated psoriatic plaques compared with uninvolved psoriatic skin (p < 0.0001), with the up-regulation of p21(WAF1/CIP1) being predominantly suprabasal. This increase was accompanied by a small increase in p53 protein expression of uncertain significance. Furthermore, p21(WAF1/CIP1) expression was induced in skin after sellotape stripping and by the application of agents, such as dithranol, that are capable of inducing hyperproliferation. The pattern of p21(WAF1/CIP1) expression observed is consistent with a role in induction and maintenance of differentiation. Our experiments, however, cannot determine whether the abnormalities of p21(WAF1/CIP1) epidermal expression in psoriasis and after insult are independent of changes in p53 expression.